Back
Apollo Asset Management, Inc. Vs. Akero Therapeutics Industry Stock Comparison
Sell
47
APO
Apollo Asset Management, Inc.
Last Price:
$145.00
Seasonality Move:
3.97%
Buy
60
AKRO
Akero Therapeutics
Last Price:
$55.59
Seasonality Move:
34.97%
Sell
47
Apollo Asset Management, Inc. (APO)
is a Sell
Is Apollo Asset Management, Inc. a Buy, Sell or Hold?
-
The current Apollo Asset Management, Inc. [APO] share price is $142.92. The Score for APO is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
APO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $56.19. The Score for AKRO is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
APO Stock Price Chart
What is Apollo Asset Management, Inc.'s stock price today?
-
The Apollo Asset Management, Inc. share price today is $142.92Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APO is experiencing slight buying pressure.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $56.19Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing slight selling pressure.
APO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.4 | Buy |
Relative Strength Index (14 RSI): | 63.1 | Buy |
Chaikin Money Flow: | 3480295 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (130.57 - 137.41) | Buy |
Bollinger Bands (100): | (126.54 - 151) | Buy |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.45 | Buy |
Relative Strength Index (14 RSI): | 67.53 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (49.33 - 55.87) | Buy |
Bollinger Bands (100): | (40.08 - 52.38) | Buy |
APO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 136.74 | Buy |
20-day SMA: | 134.59 | Buy |
50-day SMA: | 134.27 | Buy |
200-day SMA: | 145.71 | Sell |
8-day EMA: | 137.99 | Buy |
20-day EMA: | 135.95 | Buy |
50-day EMA: | 135.75 | Buy |
200-day EMA: | 137.76 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 55 | Buy |
20-day SMA: | 54.01 | Buy |
50-day SMA: | 47.06 | Buy |
200-day SMA: | 38.07 | Buy |
8-day EMA: | 55.12 | Buy |
20-day EMA: | 53.19 | Buy |
50-day EMA: | 48.99 | Buy |
200-day EMA: | 39.98 | Buy |
Apollo Asset Management, Inc. Earnings Growth & APO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.24 per share, an increase next quarter of $0.32 per share, an increase this year of $0.67 per share, and an increase next year of $1.61 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.
Apollo Asset Management, Inc. Technical Analysis
Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
13 | 16 | 17 | 18 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
13 | 16 | 17 | 18 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |